FDA Announces Joint Meeting of Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss various topics related to gastrointestinal drugs and safety